Business Context and Reporting Period
Healthcare Trust of America, Inc. (NYSE: HTA) and its operating partnership subsidiary filed this Form 8-K on September 13, 2016, reporting events occurring on September 7, 2016. The filing details an underwritten public offering of Class A common stock.
Key Financial Metrics
- Offering Size: 3,500,000 shares of Class A common stock.
- Offering Price: $33.6650 per share.
- Gross Proceeds: $117.8 million (before deducting estimated offering expenses).
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 525,000 additional shares at the same price.
- Use of Proceeds: General corporate purposes, including working capital, real estate investment, and debt repayment.
The filing text does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels as this is a current report regarding a capital raise rather than a periodic financial statement.
Material Changes
The primary material change is the increase in equity capital following the closing of the offering on September 13, 2016. Additionally, directors and executive officers entered into 60-day "lock-up" agreements restricting the sale of their shares.
Guidance, Outlook, and Risks
Management intends to utilize net proceeds for working capital, real estate investments, and debt repayment. The offering was conducted pursuant to an automatic shelf-registration statement filed in February 2015. The filing notes customary representations, warranties, and indemnification provisions within the Underwriting Agreement but does not disclose specific new risks or contingencies beyond standard underwriting terms.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and offering expenses.
- Confirm whether the underwriters exercised the 525,000 share over-allotment option within the 30-day window.
- Review the specific allocation of proceeds between debt repayment and new real estate acquisitions in subsequent filings.
- Check for any changes in the company's capital structure or leverage ratios resulting from this equity issuance.